Thomas MC - Search Results

1

Plasma low-molecular weight fluorescence in type 1 diabetes mellitus.

Januszewski AS, Thomas MC, Chung SJ, Karschimkus CS, Rowley KG, Nelson C, O'Neal D, Wang Z, Best JD, Jenkins AJ. Januszewski AS, et al. Among authors: thomas mc. Ann N Y Acad Sci. 2005 Jun;1043:655-61. doi: 10.1196/annals.1333.074. Ann N Y Acad Sci. 2005. PMID: 16037289

2

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats.

Wigg SJ, Tare M, Forbes J, Cooper ME, Thomas MC, Coleman HA, Parkington HC, O'Brien RC. Wigg SJ, et al. Among authors: thomas mc. Diabetologia. 2004 Jun;47(6):1038-46. doi: 10.1007/s00125-004-1411-x. Epub 2004 Jun 8. Diabetologia. 2004. PMID: 15184978

3

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes.

Thomas MC, Tsalamandris C, MacIsaac R, Medley T, Kingwell B, Cooper ME, Jerums G. Thomas MC, et al. Kidney Int. 2004 Sep;66(3):1167-72. doi: 10.1111/j.1523-1755.2004.00868.x. Kidney Int. 2004. PMID: 15327413 Free article.

4

Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more?

Thomas MC, Forbes JM, MacIsaac R, Jerums G, Cooper ME. Thomas MC, et al. Ann N Y Acad Sci. 2005 Jun;1043:644-54. doi: 10.1196/annals.1333.073. Ann N Y Acad Sci. 2005. PMID: 16037288 Review.

5

Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.

Roberts MA, Thomas MC, Fernando D, Macmillan N, Power DA, Ierino FL. Roberts MA, et al. Among authors: thomas mc. Nephrol Dial Transplant. 2006 Jun;21(6):1611-7. doi: 10.1093/ndt/gfl053. Epub 2006 Mar 6. Nephrol Dial Transplant. 2006. PMID: 16520354

6

Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus.

Januszewski AS, Thomas MC, Karschimkus CS, Chung JS, Rowley KG, Nelson CL, O'Neal DN, Dragicevic G, Harper CA, Best JD, Jenkins AJ. Januszewski AS, et al. Among authors: thomas mc. J Med Invest. 2008 Feb;55(1-2):29-36. doi: 10.2152/jmi.55.29. J Med Invest. 2008. PMID: 18319542 Free article.

7

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LM, Jerums G, Osicka TM. Forbes JM, et al. Among authors: thomas mc. Diabetes. 2002 Nov;51(11):3274-82. doi: 10.2337/diabetes.51.11.3274. Diabetes. 2002. PMID: 12401719

8

Role of advanced glycation end products in diabetic nephropathy.

Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Forbes JM, et al. Among authors: thomas mc. J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S254-8. doi: 10.1097/01.asn.0000077413.41276.17. J Am Soc Nephrol. 2003. PMID: 12874442 Review.

9

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME. Forbes JM, et al. Among authors: thomas mc. FASEB J. 2003 Sep;17(12):1762-4. doi: 10.1096/fj.02-1102fje. Epub 2003 Jul 18. FASEB J. 2003. PMID: 12958202

10

Elevated iron indices in patients with diabetes.

Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Thomas MC, et al. Diabet Med. 2004 Jul;21(7):798-802. doi: 10.1111/j.1464-5491.2004.01196.x. Diabet Med. 2004. PMID: 15209778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

533 results

Search Page

Filters